Phenylboronic Acid

Phenylboronic Acid

SCHEMBL6701482

NC(=O)O.OB(O)c1ccccc1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 4/20 0.74
CA4 P22748 1/20 0.74
CA6 P23280 1/20 0.74
CA5A P35218 1/20 0.74
CA7 P43166 1/20 0.74
CA14 Q9ULX7 1/20 0.74
CA5B Q9Y2D0 1/20 0.74
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
MGLL Q99685 2/20 0.54
PCSK9 Q8NBP7 1/20 0.50
ORAI1 Q96D31 1/20 0.50
ORAI2 Q96SN7 1/20 0.50
ORAI3 Q9BRQ5 1/20 0.50
TRPV6 Q9H1D0 1/20 0.50
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
PARP1 P09874 1/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylboronic Acid SCHEMBL28704052 0.90 ENPP2 (0.67) ENPP2CA4CA6CA5ACA7
Terephthalamide SCHEMBL29109497 0.86 PARP1 (0.62) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL8628436 0.86 ENPP2 (1.00) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL4453 0.86
Phenylboronic Acid SCHEMBL1723445 0.84 CA4 (0.58) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL23824843 0.84 ENPP2 (0.74) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL28944102 0.84 ENPP2 (0.74) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL17202516 0.83 ENPP2 (0.82) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL693110 0.83 ENPP2 (0.93) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL22683683 0.83 ENPP2 (0.93) ENPP2CA4CA6CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235792-A1 Serine protease inhibitors compromising a hydrogen-bond acceptor TRIGEN LIMITED (GB) 2004-11-25 US disclosed
WO-2002057273-A9 SERINE PROTEASE INHIBITORS COMPRISING A HYDROGEN-BOND ACCEPTOR TRIGEN LTD (GB) 2002-11-28 WO disclosed
WO-2002057273-A1 SERINE PROTEASE INHIBITORS COMPRISING A HYDROGEN-BOND ACCEPTOR TRIGEN LIMITED (GB) 2002-07-25 WO disclosed
EP-1046640-A2 Process for preparing substituted phenyl boronic acids Clariant GmbH (DE) 2000-10-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235792-A1 Serine protease inhibitors compromising a hydrogen-bond acceptor SERPINB1, SPINT2, CTRL ENPP2 1293/4885CA4 1246/4885CA6 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.